Login
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
.......... Issued in the interest of Investors"
OTP Verification
Regenerate OTP
Alert Message
Please contact to emkayassist@emkayglobal.com
Select Mobile Number and Email for OTP
Please select Mobile No and Email Id for OTP
Generate password
Customer Guest
Login | Register
Forgot Customer Code
Login | Register|Forgot password?
Would you like to create a personalised login id for logging in to Emkay Website ?
Change Personalised Login ID
In just concluded Meeting of Board of Directors the Board approved and considered the following items:\r\n1. Unaudited Standalone and Consolidated Fi...more...
In just concluded Meeting of Board of Directors the Board Approved and considered the following items:\r\n1. Unaudited (Standalone and Conso...more...
Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider a...more...
As of June 2026 23.63% is owned by Indian Promoters and 76.37% by Public. Top five Promoters holding highest number of shares of Gennex Labo...more...
With reference to the captioned subject matter pursuant to Regulation 74(5) of SEBI (DP) Regulations 2018 we hereby submit the certificate received f...more...
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 2...more...
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of S...more...
The company reported standalone net profit of Rs 2.99 crore for the quarter ended March 31 2026 as compared to Rs 1.50 crore in the same per...more...
In just concluded Meeting of Board of Directors the Board approved and considered the following items:\r\n1. Audited Standalone & Consolidated Financ...more...
In just concluded Meeting of Board of Directors the Board Approved and considered the following items:\r\n1. Audited Standalone & Consolidat...more...
We refer to your email of 25th May 2026 seeking clarification on your observation regarding significant movement noticed by the Exchange in the price...more...
The Exchange has sought clarification from Gennex Laboratories Ltd on May 25 2026 with reference to significant movement in price in order t...more...
Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider a...more...
In compliance to Regulation 44 of SEBI (LODR) Regulations 2015 as amended from time to time (Listing Regulations) please find enclosed herew...more...
Pursuant to Reg.30 of SEBI (LODR) Regulations 2015 we are pleased to provide hereunder the proceedings of Extraordinary General Meeting (EGM) of the ...more...
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 read with Schedule III and in furtherance to our intimation date April 16 2026 and...more...
As of March 2026 23.63% is owned by Indian Promoters and 76.37% by Public. Top five Promoters holding highest number of shares of Gennex Laboratories...more...
Revised outcome With reference to our earlier letter dated April 16 2026 in this connection we would like to submit the revised outcome of t...more...
In just concluded Meeting of Board of Directors the Board Approved and considered the following items:\r\n\r\n1. Convening of an Extraordinary Genera...more...
With reference to the captioned subject matter pursuant to Regulation 74(5) of SEBI (DP) Regulations 2018 we hereby submit the certificate r...more...
BOARD MEETINGS Company Name : Par Drugs & Chem. Date : 22-08-2026
Latest Videos